BLFS BioLife Solutions, Inc.
$38.61 0.00%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.
1D
0.00%
YTD
+46.80%
P/E
31.03
P/B
3.13
ROE
15.3%
Div yield
—
Beta
1.11
Market cap
$1.8B
RSI (14)
61
Next earnings
Nov 4, 2026
Previous session
close of Oct 6, 2026 · EOD, no live order bookOpen
$38.61
Close
$38.61
VWAP (n/a)
—
Day high
$38.61
Day low
$38.61
Volume
0
VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.
Latest headlines
Why Freshworks Stock Bumped Higher Today
Yahoo Finance · Oct 6
Repligen Completes Acquisition of BioLife Solutions
Yahoo Finance · Oct 6
Freshworks stock climbs on S&P SmallCap 600 inclusion
Investing.com · Oct 5
BioLife Solutions Shareholders Approve Repligen Merger Agreement
Yahoo Finance · Oct 5
This Long-Term Winning Stock Is in a Growth Market and Just Hit New 3-Year Highs
Yahoo Finance · Sep 24
BioLife Solutions (BLFS) Is Up 7.2% After Swinging From Loss To Q2 Profit - What's Changed
Yahoo Finance · Aug 7
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
8-K Oct 6, 2026 View → 8-K Sep 9, 2026 View → 10-Q Aug 6, 2026 View → 8-K Aug 6, 2026 View → 8-K Aug 3, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell BLFS. Try it in the Lab to size a position and see the risk.